Baker Brothers Advisors - LA JOLLA PHARMACEUTICAL CO ownership

LA JOLLA PHARMACEUTICAL CO's ticker is LJPC and the CUSIP is 503459604. A total of 98 filers reported holding LA JOLLA PHARMACEUTICAL CO in Q3 2017. The put-call ratio across all filers is 11.54 and the average weighting 0.6%.

Quarter-by-quarter ownership
Baker Brothers Advisors ownership history of LA JOLLA PHARMACEUTICAL CO
ValueSharesWeighting
Q3 2019$13,721,000
-4.9%
1,559,2310.0%0.09%
-5.1%
Q2 2019$14,423,000
+343.9%
1,559,231
+208.6%
0.10%
+366.7%
Q1 2019$3,249,000
+122.7%
505,240
+226.6%
0.02%
+75.0%
Q4 2018$1,459,000
-53.1%
154,6750.0%0.01%
-42.9%
Q3 2018$3,114,000
-31.0%
154,6750.0%0.02%
-38.2%
Q2 2018$4,512,000
-2.0%
154,6750.0%0.03%
-12.8%
Q1 2018$4,606,000
-7.5%
154,6750.0%0.04%
-9.3%
Q4 2017$4,977,000
-7.5%
154,6750.0%0.04%
-2.3%
Q3 2017$5,380,000
-64.2%
154,675
-69.4%
0.04%
-66.4%
Q2 2017$15,026,000
+32.8%
504,732
+33.1%
0.13%
+40.9%
Q1 2017$11,317,000
+4595.9%
379,134
+2658.1%
0.09%
+4550.0%
Q4 2016$241,000
-26.3%
13,7460.0%0.00%
-33.3%
Q3 2016$327,000
+48.6%
13,7460.0%0.00%
+50.0%
Q2 2016$220,000
-23.3%
13,7460.0%0.00%
-33.3%
Q1 2016$287,000
-22.6%
13,7460.0%0.00%0.0%
Q4 2015$371,000
-96.8%
13,746
-96.7%
0.00%
-97.2%
Q3 2015$11,450,000
+13.4%
412,0080.0%0.11%
+19.1%
Q2 2015$10,098,000
+33.9%
412,0080.0%0.09%
+41.3%
Q1 2015$7,540,000
-3.1%
412,008
-2.3%
0.06%
-20.3%
Q4 2014$7,779,000
+92.0%
421,6310.0%0.08%
+54.9%
Q3 2014$4,052,000
+99.1%
421,631
+90.2%
0.05%
+104.0%
Q2 2014$2,035,000
-15.0%
221,6310.0%0.02%
-16.7%
Q1 2014$2,394,000221,6310.03%
Other shareholders
LA JOLLA PHARMACEUTICAL CO shareholders Q3 2017
NameSharesValueWeighting ↓
TANG KEVIN C 240,000$1,027,00095.09%
TANG CAPITAL MANAGEMENT LLC 10,049,224$43,011,0008.56%
RTW INVESTMENTS, LP 2,327,903$9,963,0000.15%
Boxer Capital, LLC 890,700$3,812,0000.13%
Tibra Equities Europe Ltd 72,600$311,0000.10%
WealthTrust Axiom LLC 25,400$108,0000.04%
GSA CAPITAL PARTNERS LLP 52,749$226,0000.02%
FIRST MIDWEST BANK TRUST DIVISION 34,231$147,0000.02%
HOLLENCREST CAPITAL MANAGEMENT 42,355$181,0000.02%
Summit Global Investments 48,500$208,0000.01%
View complete list of LA JOLLA PHARMACEUTICAL CO shareholders